UPDATE: Morgan Stanley Downgrades Sarepta Therapeutics (SRPT) to Equalweight
Tweet Send to a Friend
(Updated - January 8, 2021 6:25 AM EST)
Morgan Stanley analyst Matthew Harrison downgraded Sarepta Therapeutics (NASDAQ: SRPT) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Morgan Stanley analyst Matthew Harrison downgraded Sarepta Therapeutics (NASDAQ: SRPT) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
